Planned sale of 13,900 SNX common shares

A shareholder of SNX has filed a Form 144 notice to sell 13,900 shares of common stock through Morgan Stanley Smith Barney LLC on or about February 6, 2026 on the NYSE, with an indicated aggregate market value of $2,384,860.53.

Rhea-AI Filing Summary

A shareholder of SNX has filed a Form 144 notice to sell 13,900 shares of common stock through Morgan Stanley Smith Barney LLC on or about February 6, 2026 on the NYSE, with an indicated aggregate market value of $2,384,860.53.

The filing notes that these are common shares, and shows total common shares outstanding of 80,729,152, giving context for the planned sale size. The shares to be sold were acquired in several restricted stock grants from the issuer during 2025 and early 2026, all listed as fully paid in stock rather than cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SNX Form 144 filing disclose?

The Form 144 for SNX discloses a planned sale of 13,900 common shares with an aggregate market value of $2,384,860.53, to be executed through Morgan Stanley Smith Barney LLC on or about February 6, 2026 on the NYSE.

How many SNX shares are planned to be sold under this Form 144?

The filing shows a planned sale of 13,900 common shares of SNX. These shares are listed with an aggregate market value of $2,384,860.53, providing an indication of the transaction’s size relative to typical insider sales.

What is the aggregate market value of SNX shares in this planned sale?

The planned sale has an indicated aggregate market value of $2,384,860.53. This value is tied to the 13,900 SNX common shares listed in the Form 144 and reflects the approximate dollar size of the intended transaction on the NYSE.

Which broker will handle the planned SNX Form 144 share sale?

The planned sale of SNX shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is listed as 1 New York Plaza, 8th Floor, New York, NY 10004, and the sale is expected to occur on the NYSE.

When is the SNX Form 144 sale expected to occur and on which exchange?

The Form 144 indicates an approximate sale date of February 6, 2026 for the 13,900 SNX common shares. The shares are expected to be sold on the NYSE, providing a time frame and venue for the planned transaction.

How many SNX common shares are outstanding according to this filing?

The filing lists 80,729,152 common shares of SNX outstanding. This figure offers context for evaluating the relative size of the planned 13,900-share sale disclosed in the Form 144 notice, though it does not change the sale amount itself.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/06/2026 - 05:31 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001629773
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TD SYNNEX CORPORATION
SEC File Number	001-31892
Address of Issuer	44201 Nobel Drive Fremont CALIFORNIA 94538
Phone	510-668-3400
Name of Person for Whose Account the Securities are To Be Sold	PATRICK ZAMMIT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	13900	2384860.53	80729152	02/06/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/05/2026	Restricted Stock	Issuer			2529	01/05/2026	Not Applicable
Common	10/15/2025	Restricted Stock	Issuer			6072	10/15/2025	Not Applicable
Common	10/04/2025	Restricted Stock	Issuer			912	10/04/2025	Not Applicable
Common	03/31/2025	Restricted Stock	Issuer			2734	03/31/2025	Not Applicable
Common	10/03/2025	Restricted Stock	Issuer			1653	10/03/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/06/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Patrick Zammit
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)